Advanced company searchLink opens in new window

PHARMARON BIOLOGICS (UK) HOLDINGS LIMITED

Company number 13055953

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
13 Mar 2024 DISS40 Compulsory strike-off action has been discontinued
12 Mar 2024 GAZ1 First Gazette notice for compulsory strike-off
07 Mar 2024 AA Full accounts made up to 31 December 2022
04 Jan 2024 SH01 Statement of capital following an allotment of shares on 29 December 2023
  • USD 357,500,000
13 Dec 2023 CS01 Confirmation statement made on 1 December 2023 with updates
09 Jun 2023 PSC01 Notification of Bei Zheng as a person with significant control on 2 December 2020
09 Jun 2023 PSC01 Notification of Boliang Lou as a person with significant control on 2 December 2020
09 Jun 2023 PSC01 Notification of Xiaoqiang Lou as a person with significant control on 2 December 2020
09 Jun 2023 PSC09 Withdrawal of a person with significant control statement on 9 June 2023
16 May 2023 AP04 Appointment of Oakwood Corporate Secretary Limited as a secretary on 2 December 2022
07 Dec 2022 CS01 Confirmation statement made on 1 December 2022 with no updates
07 Dec 2022 SH01 Statement of capital following an allotment of shares on 2 December 2022
  • USD 200,000,000
01 Dec 2022 AA Full accounts made up to 31 December 2021
20 Oct 2022 CH01 Director's details changed for Dr. Boliang Lou on 7 January 2022
20 Oct 2022 CH01 Director's details changed for Gilbert Shing Chung Li on 2 December 2020
24 Dec 2021 CS01 Confirmation statement made on 1 December 2021 with no updates
23 Jun 2021 AD01 Registered office address changed from West Hill Innovation Park Hertford Road Hoddesdon Hertfordshire EN11 9FH United Kingdom to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 23 June 2021
02 Dec 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2020-12-02
  • USD 10,000